--- title: "Governance" description: "IFAPP is comprised of three governing bodies: The Board of Officers The House of Delegates The General Assembly The Board of Officers The Board of Officers is in charge of IFAPP's day-to-day management and has the broadest powers to do" url: https://ifapp.org/about-ifapp/governance/ date: 2024-08-31 modified: 2025-04-15 author: "Miguel Espí" type: page lang: en-GB --- # Governance IFAPP is comprised of three governing bodies: - The Board of Officers - The House of Delegates - The General Assembly ## The Board of Officers The Board of Officers is in charge of IFAPP’s day-to-day management and has the broadest powers to do all that is necessary or useful to achieve IFAPP’s goals. The Board is comprised of five officers, President, President Elect, Past President, Secretary and Treasurer, plus five Scientific Chairs The current members of the IFAPP Board of Officers are listed below. The President will serve a two-year term, from 2025 to 2027, at the conclusion of which the President-elect will take over and the House of Delegates will elect a new President-elect at the International Conference on Pharmaceutical Medicine (ICPM). If you wish to contact any member of the Board of Officers below please get in touch with: **IFAPP secretariat** p/a Business2gether Leidsestraatweg 41-D 3443 BP WOERDEN The Netherlands Chamber of Commerce: 30224375 **E-mail: **[**secretariat@ifapp.org**](https://web.archive.org/web/20240513034059/mailto:secretariat@ifapp.org) Phone: +31 6 2291 1039 ### President Eric Klaver (The Netherlands) More info ![" class="wp-image-9521" srcset="https://ifapp.org/wp-content/uploads/2024/09/Eric-circle-460e3760224d87d5499b0c611e657c05-xu4ag2knjqio-150x150.avif 150w, https://ifapp.org/wp-content/uploads/2024/09/Eric-circle-460e3760224d87d5499b0c611e657c05-xu4ag2knjqio-300x300.avif 300w, https://ifapp.org/wp-content/uploads/2024/09/Eric-circle-460e3760224d87d5499b0c611e657c05-xu4ag2knjqio-jpg.avif 305w" sizes="(max-width: 150px) 100vw, 150px" /> Eric became president of IFAPP at ICPM2025, succeeding Varvara Baroutsou. Eric is board member of the Dutch member association, NVFG, since 2021, and has since then chaired the ClinOps division of NVFG (2021-2024), functioned as treasurer (2024-now) and has functioned as vice-chair in the NVFG board since 2023. Eric has spent 30+ years in the pharmaceutical industry. After studying medicine, the choice was made to opt for a career in this field. Eric has held many roles, amongst which data-manager, CRA, Project Lead, Program Manager and QA consultant. For almost 25 years Eric has worked as a clinical research trainer, 16 of those independent, and he added auditing to his portfolio about 8 years before ending his last independent stint. Since October 2021, Eric works for IQVIA, for 2 years as the DCT Regulatory Director, and currently as Director Information Governance. ### President-elect Kotone Matsuyama (Japan) More info Nikos Tsokanas, BSc (Hons), MSc, MBA, Six Sigma Black Belt Certified, is a lean-thinking digital leader with over 20 years of experience in the Pharma Industry, strong IT capabilities and strategic vision, keen bottom-line focus, and verifiable success in optimising efficiency and increasing quality of results through delivery of value-added services and novel technologies. Proven track of success enhancing agile Project Management, creating and maintaining processes, organising audit, managing budgets, and providing updates on project status in large pharmaceutical companies across the UK and Greece. Demonstrating in-depth knowledge of digital capabilities, GxP validation and regulatory frameworks. Elite communicator combined with the ability to convey information in a clear, focused, and concise manner. Nikos Tsokanas has held different positions in BAYER HELLAS S.A, Athens, Greece since 2015: Quality System Manager, developing and maintaining high-standard Quality Management System for local R&D functions; Head of Medical Operations & Quality System with responsibilities to ensure that medical operational activities in Bayer Hellas are efficiently executed, while leading a group of 3 direct reports; Medical Operations & Excellence Cluster Head, managing medical operation activities across a cluster of five countries, while leading a group of 5 direct reports and with temporary assignment as Medical Digital Lead for EMEA, ensuring digital excellence across Medical teams, integrating and optimizing digital solutions for customer engagement within Medical Affairs throughout Europe, Middle East and Africa. Within professional development, Nikos obtained the the following qualifications: - Practical Approach to Audit Systems by Research Quality Association, UK - Audit Programs & Risk Assessment by Research Quality Association, UK - Auditor/Lead Auditor of Quality Management Systems (ISO9001:2008) by University of Piraeus, GR - Project Management Professional (PMP) Certification preparation (35 hrs) by Critical Path Consulting, GR - Good Clinical Practice Auditing – Principles and Practice by Research Quality Association, UK - Certificate on Good Clinical Practice by Astra Nova Ltd, UK - SIX SIGMA, Black Belt Certification by Aveta Business Institute, US - Management of ICSRs and Medicinal Products in EudraVigilance by Drug Information Association, EU Currently, Nikos is member of the Board of Directors, Hellenic Society of Pharmaceutical Medicine (EL.E.F.I.), Greece (institutional member of IFAPP) and of the Research Quality Association. Previously, he acted as Secretary of Digital Information Governance & Information Technology Working Group, Research Quality Association, UK and was member of International Society of Pharmacovigilance, Drug Information Association and Pharmacovigilance Group at SFEE. ### Scientific Chair Ghazaleh Gouya (Austria) Chair of Communication Working Group. Gouya-Insights kg More info Robert Lins is MD and certified specialist in Internal Medicine, Nephrology and Hypertension. He has a PhD in Medical Sciences, is European Hypertension Specialist and Fellow of the Belgian College of Pharmaceutical Physicians. He was a Clinical Professor at the Department of Internal Medicine, University of Antwerpen. Since many years he is a board member of the and currently the President. He is member of different local and international scientific societies and was most recently president of the Belgian Association of Clinical Research Professionals (ACRP.be), now Healixia. He worked during many years as director of the department of Nephrology-Hypertension at Stuivenberg hospital in Antwerp, Belgium, before becoming general manager of one of the hospitals, belonging to the Hospital Network of Antwerpen (ZNA). He started a Clinical Pharmacology Unit in Stuivenberg hospital in 1987, that was acquired later by SGS. From 2007 until 2011 he was Managing Director of SGS Life Science Services Clinical Research. Since then, he is continuing his activity as a consultant. Currently he is Managing Director of Linsconsulting and Project Director Respiratory Diseases for SGS Life Sciences. He published over 100 articles in international peer-reviewed journals. ### Scientific Chair Joanne Ramsey (Ireland) Chair of the Young Professionals WG More info